Tussionex


Also found in: Dictionary.

Tussionex

a trademark for a fixed-combination drug containing an antitussive (hydrocodone) and an antihistamine (phenyltoloxamine citrate).
Mentioned in ?
References in periodicals archive ?
The resin chosen was AMBERLITE IRP69, a resin similar to that used in Delsym and Tussionex.
The reports indicate that physicians and other health professionals have prescribed Tussionex for children under age 6, or more frequently than the labeled dosing interval of every 12 hours.
Tussionex and cough syrup didn't help, and cortisone seems to make it worse.
Our main brand, Tussionex, the unique 12-hour anti-tussive, achieved sales of (pound)29 million a 48% increase on 1997 levels.
This decline was partially offset by the strong performance from a number of other products, notably Tussionex and Zaroxolyn.
Nasdaq: CRTX) ("Cornerstone" or the "Company"), a specialty pharmaceutical company focused on acquiring, developing and commercializing significant products primarily for the respiratory and related markets, today announced that its product candidate CRTX-067 is an ANDA filing for a generic 10 mg chlorpheniramine polistirex/8 mg hydrocodone polistirex suspension product that will be a generic substitute for the product currently sold under the Tussionex brand name by UCB, Inc.
With 185 sales people operating in 12 regional business units, our salesforce is of an appropriate size to support our highly targeted niche marketing strategy and its positive impact is becoming increasingly evident with promising growth in prescriptions written for Tussionex, Zaroxolyn and Pediapred in the second half of 1997.
To date, its roster of clients includes Genentech for Herceptin (Trastuzumab), a treatment for breast cancer; UCB for Tussionex (hydrocodone and chlorpheniramine) a cough/cold product; Integra Life Sciences for a spinal fusion product; Enzon for Abelcet, an IV anti-fungal agent, Novogyne (Noven and Novartis) for Vivelle Dot (estradiol transdermal system), a hormone replacement patch, Valera for Valstar (Valrubicin) a bladder cancer agent, Vantas for prostate cancer and Supprelin for precocious puberty.
The 33% increase in sales of respiratory products was driven by two of these, Tussionex and Semprex-D.
Flashpoint's clients, to date, include Genentech for Herceptin, a treatment for breast cancer; UCB for Tussionex, Integra Life Sciences for Mozaik, a spinal fusion product; Noven for Vivelle Dot, a hormone replacement patch, and Valera for Valstar and projects for Vantas, treatments for bladder and prostate cancer.
Codeprex, Tussionex, Delsym and Pennkinetic are trademarks of Celltech.
Sales of Major Products 2002 2001* % change pounds m pounds m Tussionex 71.